Patents by Inventor Margareta Frohm Nilsson

Margareta Frohm Nilsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7741275
    Abstract: The present invention provides agents for inhibiting the proliferation of cancer cells, wherein the agent inhibits the biological activity of hCAP18/LL-37. In a preferred embodiment, the agent alters the transcription, translation and/or binding properties of hCAP18/LL-37. Preferably, the agent is selected from the group consisting of short interfering RNA (siRNA) molecules, antisense oligonucleotides and compounds with binding affinity for hCAP18/LL-37. The invention further provides methods for inhibiting the proliferation of cancer cells in a patient, as well as methods and kits for diagnosing cancer.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: June 22, 2010
    Assignee: Lipopeptide AB
    Inventors: Mona Ståhle, Johan Heilborn, Margareta Frohm Nilsson, Gunter Weber
  • Publication number: 20080187530
    Abstract: The present invention provides agents for inhibiting the proliferation of cancer cells, wherein the agent inhibits the biological activity of hCAP18/LL-37. In a preferred embodiment, the agent alters the transcription, translation and/or binding properties of hCAP18/LL-37. Preferably, the agent is selected from the group consisting of short interfering RNA (siRNA) molecules, antisense oligonucleotides and compounds with binding affinity for hCAP18/LL-37. The invention further provides methods for inhibiting the proliferation of cancer cells in a patient, as well as methods and kits for diagnosing cancer.
    Type: Application
    Filed: December 16, 2005
    Publication date: August 7, 2008
    Applicant: Lipopeptide AB
    Inventors: Mona Stahle, Johan Heilborn, Margareta Frohm Nilsson, Gunther Weber